文献速递泌尿生殖技术与安全MR

前列腺癌MRI方法学影像组学评分:EuSoMII影像组学审计组倡议

Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative.
PubMed 文献 · Eur Radiol · 2024-12-30

该研究通过METRICS评分评估前列腺癌MRI影像组学研究的质量,检索2019年7月1日至2023年11月30日文献,纳入185篇手稿。平均METRICS总分为52%±16%,亚组间无统计学显著差异。研究显示近期前列腺癌MRI影像组学研究质量总体中等且同质性良好,但指南依从性、混杂因素处理、外部测试及数据/代码/模型可用性方面得分较低。

要点

  • 平均METRICS总分为52%±16%,前列腺癌MRI影像组学研究质量总体中等。
  • 指南/检查清单依从性仅4.9%,混杂因素处理14.1%,外部测试15.1%。
  • 数据、代码和模型可用性分别仅15.7%、4.3%和1.6%。

核心结论

  • 近期前列腺癌MRI影像组学研究质量显示良好同质性且总体中等,平均METRICS总分为52%±16%,亚组间无统计学显著差异。

研究设计与样本

  • 文献检索2019年7月1日至2023年11月30日,纳入185篇评估前列腺癌MRI影像组学的原创研究,由7名不同专业水平的读者使用METRICS进行质量评估,并按论文类别(诊断、分期、预后、技术)进行亚组分析。

诊断标准与关键数值

  • 平均METRICS总分为52%±16%;指南/检查清单依从性4.9%,混杂因素处理14.1%,外部测试15.1%,数据可用性15.7%,代码可用性4.3%,模型可用性1.6%;患者选择标准明确86.5%,高质量参考标准89.2%,影像协议描述良好85.9%,临床适用87%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the quality of radiomics research in prostate MRI for the evaluation of prostate cancer (PCa) through the assessment of METhodological RadiomICs (METRICS) score, a new scoring tool recently introduced with the goal of fostering further improvement in radiomics and machine learning methodology.

MATERIALS AND METHODS: A literature search was conducted from July 1st, 2019, to November 30th, 2023, to identify original investigations assessing MRI-based radiomics in the setting of PCa. Seven readers with varying expertise underwent a quality assessment using METRICS. Subgroup analyses were performed to assess whether the quality score varied according to papers' categories (diagnosis, staging, prognosis, technical) and quality ratings among these latter.

RESULTS: From a total of 1106 records, 185 manuscripts were available. Overall, the average METRICS total score was 52% ± 16%. ANOVA and chi-square tests revealed no statistically significant differences between subgroups. Items with the lowest positive scores were adherence to guidelines/checklists (4.9%), handling of confounding factors (14.1%), external testing (15.1%), and the availability of data (15.7%), code (4.3%), and models (1.6%). Conversely, most studies clearly defined patient selection criteria (86.5%), employed a high-quality reference standard (89.2%), and utilized a well-described (85.9%) and clinically applicable (87%) imaging protocol as a radiomics data source.

CONCLUSION: The quality of MRI-based radiomics research for PCa in recent studies demonstrated good homogeneity and overall moderate quality.

KEY POINTS: Question To evaluate the quality of MRI-based radiomics research for PCa, assessed through the METRICS score. Findings The average METRICS total score was 52%, reflecting moderate quality in MRI-based radiomics research for PCa, with no statistically significant differences between subgroups. Clinical relevance Enhancing the quality of radiomics research can improve diagnostic accuracy for PCa, leading to better patient outcomes and more informed clinical decision-making.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cavallo AU, Stanzione A, Ponsiglione A, et al. Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative. Eur Radiol. 2024. PMID: 39739041. doi:10.1007/s00330-024-11299-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。